Search Within
Document Type
89-93-0
Applied Filters:
Keyword:'89-93-0'
Showing 1-30 of 273 results for "89-93-0" within Technical Documents
The Effective Use of Protein Kinase Inhibitors
90 100 58 60 1 0 0 0 80 36 102 110 77 70 93 99 21 34 99 78 85 79
91 96 86 98 58 68 46 7 97 22 11 15 19 0 1 77 8
The Effective Use of Protein Kinase Inhibitors
90 100 58 60 1 0 0 0 80 36 102 110 77 70 93 99 21 34 99 78 85 79
91 96 86 98 58 68 46 7 97 22 11 15 19 0 1 77 8
Poster: Purification with Millipore MultiScreen 384SEQ Plates on Beckman-Coulter’s Biomek FX for High Quality Direct Sequencing in High-Throughput Genomics
365.39 93%
il12a_1 zq 39.78 400.66 98% il12a_1 zq 41.14 383.16 88% il12a_1 zq 44.93 452.26 98%
il12a_7-A yq r1 15.65 0 0% il12a_7-A yq r1 0 0 0% il12a_7-A yq r1 40.95 411.51 97%
il12a_7-A yq r2 0 0 0% il12a
MILLIPLEX®MAP Human Myokine Panel is an optimized quantitative immunoassay that simultaneously measures 15 novel muscle-secreted factors
OSM IL-6 FGF21 Musclin
1:4 dil 64 79 139 94 110 89 67 99 79 114
1:8 dil 49 54 150 98 111 86 79 89 66 124
1:16 dil 93 79 120 118 89 95 109
Poster: Protein Capture with Salt Tolerant CEX
Eshmuno®
CPS, high
salt
84 89 0 55 1.5 2.0 100 0 2.1
Eshmuno®
CPX, high
salt
40 93 0 79 1.5 2.0 100 0 1.0
Conven-
tional
CEX, plus
inline
dilution
90 93
Application Note - Detection and quantification of leached Protein A from Eshmuno A resin using Cygnus F400 Protein A ELISA kit
5.02 85% 605.2
0.788 4.973
1 1600
0.352
0.348
2.678
2.68 93% 556.8
0.344 2.673
2 1600
0.272
0.294
2.579
2.52 89% 470.4
0.316 2.455
1 3200
0186
0.184
1.376
1.36 94% 588.8
0.182
Biological Evaluation of the MILLIPLEX®MAPMouse High Sensitivity T Cell Panel
.61 30.1 0 0 0.23 0 53 5.89
(+) PMA 10.3 2.12 26.0 4.35 0 0.18 1.04 71 4.05
(+) PHA 10.3 2.33 23.9 0 0 0.23 0 59 5.43
(+) Con A 11.3 3.74 29.6 0 0 0.21 0 56 5.84
(+) LPS
Biological Evaluation of the MILLIPLEX®MAP Mouse High Sensitivity T Cell Panel
Unstimulated Cells 13.8 2.61 30.1 0 0 0.23 0 53 5.89
(+) PMA 10.3 2.12 26.0 4.35 0 0.18 1.04 71 4.05
(+) PHA 10.3 2.33 23.9 0 0 0.23 0 59 5.43
(+) Con A 11.3
Protocol- EZHS100B-33K
204.5 85
4
0 14.8 - -
25 40 36.5 92
74 89 86.2 97
222 237 236.8 100
5
0 11 - -
LABORATORY NOTEBOOK ISSUANCE PAGE
(2
09
)
(2
10
)
(2
22
)
(2
84
)
(2
89
)
(2
88
)
(2
93
)
(2
94
)
(2
94
)
Fl
Lv
16
7.
26
16
8.
93
17
3.
05
17
LABORATORY NOTEBOOK ISSUANCE PAGE
(2
09
)
(2
10
)
(2
22
)
(2
84
)
(2
89
)
(2
88
)
(2
93
)
(2
94
)
(2
94
)
Fl
Lv
16
7.
26
16
8.
93
17
3.
05
17
LABORATORY NOTEBOOK ISSUANCE PAGE
(2
09
)
(2
10
)
(2
22
)
(2
84
)
(2
89
)
(2
88
)
(2
93
)
(2
94
)
(2
94
)
Fl
Lv
16
7.
26
16
8.
93
17
3.
05
17
Periodic Table of the Elements - Certipur ICP multi-element standards according to USP <232> - EMD
3d24s2
23 50.942 1910
3407
1.45V
0, 2, 3, 4, 5
[Ar] 3d34s2
24 51.996 1907
2671
1.56Cr
0, 2, 3, 6
[Ar] 3d54s1
25 54.938 1246
2061
1.60Mn
-1, 0, 2, 3, 4
High-Volume Vacuum or Pressure Pump User Guide
Operating temperature 1°C to 40°C
Safety compliance 115 V CSA approved
220 V CE compliant - 89/356/EEC
89/392/EEC
91/368/EEC
Ordering Information
Description Catalogue Number
Vacuum/pressure pump
User Guide-MILLIPLEX® Human Cytokine/Chemokine/Growth Factor Panel B Magnetic Bead Panel
Matrix
6CKine 94% 89%
BCA-1 90% 87%
sFas 89% 83%
sFasL 90% 90%
sCD137 93% 92%
APRIL 93% 90%
BAFF 94% 93%
IL-16 87%
User Guide-HCYTB60K
Matrix
6CKine 94% 89%
BCA-1 90% 87%
sFas 89% 83%
sFasL 90% 90%
sCD137 93% 92%
APRIL 93% 90%
BAFF 94% 93%
IL-16 87%
Product Information Sheet - SE120032
Observed
Value
Expected
Value Recovery (%)
31 45.2 46.9 96
93 75.6 77.9 971 62.8
280 152.8 171.4 89
31 152.2 160 95
93 176 191 922 289
280 288.2 284.5 101
References
1. Pirker, R.A. et al
Relationship of MC-Media Pad E. coli & Coliform Plate Results with the Most Probable Number Method
87 1.940 1.847 70.333
88 1.944 1.852 71.103
89 1.949 1.857 71.872
90 1.954 1.861 72.641
91 1.959 1.866 73.410
92 1.964 1.870 74.178
93 1.968 1.875 74.946
94 1.973 1.879 75.713
User Guide-RAB0277
115
Plasma 98 89-108
Cell Culture Supernatants 93 81-109
Linearity
Sample Type Serum Plasma Cell Culture Supernatants
1:2
Average % of Expected 107 104 132
Range (%) 93-114 91-113 120-139
User Guide-RAB1298
Recovery Range (%)
Serum 114 93-129
Plasma 98 89-115
Cell Culture Media 116 107-125
Linearity
Sample Type Serum Plasma Cell Culture Media
1:2
Average % of Expected 93 98 105
Range (%) 76-111
Product Information Sheet - M7888
cells
by a Drosophila ecdysone receptor and chimeric
transactivators. Proc. Natl. Acad. Sci. USA,
89(14), 6314-6318 (1992).
GCY/CRF 12/03
Sigma brand products are sold through Sigma-Aldrich
Monitoring low dose API blend uniformity with Parteck® M
Calibration
(n=5)
Validation
(n=10)
Test
(n=10)
70 1 0 0
80 1 0 0
90 1 1 0
100 1 1 3
110 1 1 0
120 1 0 0
130
Product Information Sheet - M2128
to
the tetrazolium dye procedure giving improved
sensitivity and reliability. J. Immunol. Methods, 89,
271-277 (1986).
7. Carmichael, J., et al., Evaluation of a tetrazolium-
based semiautomated colorimetric
MAK415 - Technical Bulletin
well)
1 0 L 95 L 0
2 2 L 93 L 4
3 4 L 91 L 8
4 6 L 89 L 12
5 8 L 87 L 16
6 10 L 85 L 20
Periodic table A4
Unknown title
S
ta
n
d
:
0
1
/2
0
1
7
W
.2
8
0
7
1
8
The life science business of Merck
Protocol- MCYT1-190K|MCYT1-190K-SPX|MCYT1-190K-SPXBK|MCYT1-190K-LPX|MCYT1-190K-LPXBK
97
IL-33 93 99
IFNγ 94 100
IL-1α 94 94
IL-17F 91 103
IL-1β 93 102
IL-2 83 89
IFNβ 95 100
IL-4 89
MultiScreen Ultracel®-10 filter plate: Nucleic Acid Applications
- 301 bp
100 uL 300 uL 100 uL 300 uL
137 bp 90 82 84 97
301 bp 96 90 90 89
657 bp 97 93 91 94
1159 bp 100 93 92 94
Percent Recovery of Double-stranded DNA
0.1 ug
User Guide-RAB1498
Serum 80 70-89
Plasma 76 70-80
Cell Culture Supernatants 73 69-81
Linearity
Sample Type Serum Plasma Cell Culture Supernatants
1:2
Average % of Expected 88 98 95
Range (%) 83-93 91-106 90
User Guide-RAB0035
Supernatants 78 69-89
Linearity
Sample Type Serum Plasma Cell Culture Supernatants
1:2
Average % of Expected 86 98 100
Range (%) 75-94 91-105 93-106
1:4
Average % of Expected Range 77 89 81
Range
User Guide-RAB0212
Supernatants 98 89-108
Linearity
Sample Type Serum Plasma Cell Culture Supernatants
1:2
Average % of Expected 95 94 97
Range (%) 91-103 89-105 89-106
1:4
Average % of Expected Range 98 96 93
Range
Page 1 of 10